Michelle Aries, PhD, is a first-generation college student who was born and raised in a small farming town in Southern Oregon. She received her BS in biochemistry from Southern Oregon University before attending graduate school at Montana State University, where she conducted research on metabolomics and bacterial resistance and received her PhD in biochemistry. She is a member of the research group of Dr. Hensley-McBain where she is now working and contributing to advancing biomedical research in Alzheimer’s disease; she also serves as an instructor in physiology.

Education

• BS, Biochemistry, Southern Oregon University
• PhD, Biochemistry, Montana State University

Research

Research interest: Alzheimer’s disease

Publications

• Aries M, Cook M, Hensley-McBain T, et. al. "Peripheral Low Level Chronic LPS Injection as a Model of Neutrophil Activation in the Periphery and Brain in Mice." Research square, (), (2023) . pii: rs.3.rs-3443401. doi: 10.21203/rs.3.rs-3443401/v1
• Aries ML, Hensley-McBain T. "Neutrophils as a potential therapeutic target in Alzheimer's disease." Frontiers in immunology, 14(), (2023) 1123149. doi: 10.3389/fimmu.2023.1123149
• Aries ML, Cloninger MJ. "NMR Hydrophilic Metabolomic Analysis of Bacterial Resistance Pathways Using Multivalent Antimicrobials with Challenged and Unchallenged Wild Type and Mutated Gram-Positive Bacteria." International journal of molecular sciences, 22(24), (2021) . doi: 10.3390/ijms222413606
• Aries ML, Cloninger MJ. "NMR metabolomic analysis of bacterial resistance pathways using multivalent quaternary ammonium functionalized macromolecules." Metabolomics : Official journal of the Metabolomic Society, 16(8), (2020) 82. doi: 10.1007/s11306-020-01702-1

View All Publications